Superior in vitro activity of ertapenem and piperacillin/tazobactam against recent clinical isolates of Proteus mirabilis from intra-abdominal infections (SMART 2009-2010)

Int J Antimicrob Agents. 2011 Aug;38(2):186-7. doi: 10.1016/j.ijantimicag.2011.04.008. Epub 2011 May 31.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Abscess / microbiology*
  • Anti-Bacterial Agents / pharmacology*
  • Ertapenem
  • Humans
  • Microbial Sensitivity Tests
  • Penicillanic Acid / analogs & derivatives
  • Penicillanic Acid / pharmacology
  • Piperacillin / pharmacology
  • Piperacillin, Tazobactam Drug Combination
  • Proteus Infections / microbiology*
  • Proteus mirabilis / drug effects*
  • Proteus mirabilis / isolation & purification
  • beta-Lactams / pharmacology*

Substances

  • Anti-Bacterial Agents
  • beta-Lactams
  • Piperacillin, Tazobactam Drug Combination
  • Penicillanic Acid
  • Ertapenem
  • Piperacillin